Home/Stocks/NRSN

NRSN

USD

NeuroSense Therapeutics Ltd. Ordinary Shares

$1.040-0.010 (-0.952%)

Real-time Price

Healthcare

Biotechnology

Israel

Price Chart

Loading Chart...

Key Metrics

Market Metrics

Company Fundamentals

Trading Stats

Market Metrics

Open

$1.050

High

$1.100

Low

$1.020

Volume

0.03M

Company Fundamentals

Market Cap

30.7M

Industry

Biotechnology

Country

Israel

Trading Stats

Avg Volume

0.60M

Exchange

NCM

Currency

USD

52-Week Range

Low $0.8Current $1.040High $2.6

AI Analysis Report

Last updated: Oct 31, 2025

AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

NRSN: A Biotech Bargain With Technical Headwinds

Overview

NeuroSense Therapeutics Ltd (NRSN) trades at $1.03 as of October 30, 2025, nearing its 52-week low of $0.80. The clinical-stage biotech focuses on ALS, Alzheimer's, and Parkinson's treatments, with PrimeC in late-stage trials. Despite a bearish technical setup, its P/E ratio (-1.88x) undercuts the industry average (-2.8x), suggesting potential undervaluation.

Key Technical Signals

Weak Bearish Momentum

DMI Indicator: A bearish trend is detected (ADX:13.2, +DI:8.8, -DI:16.7), though weak trend strength reduces reliability.
MACD Death Cross: Bearish momentum with MACD (-0.0026) below signal line (-0.0022), but the narrow gap implies limited urgency.